Marie-Ève Routhier

A phase 2 study of trametinib for patients with pediatric glioma or plexiform neurofibroma with refractory tumor and activation of the MAPK/ERK pathway: TRAM-01

Sébastien Perreault, Valérie Larouche, Uri Tabori et al. · BMC Cancer · 2019 · 144 citations · Full text

Neuropsychological outcomes of a randomized trial of prednisone versus dexamethasone in acute lymphoblastic leukemia: Findings from Dana-Farber Cancer Institute All Consortium Protocol 00-01

Deborah P. Waber, Marie McCabe, Mikaela Sebree et al. · Pediatric Blood & Cancer · 2013 · 30 citations · Full text

Impact of trametinib on the neuropsychological profile of NF1 patients

Ève Lalancette, Édith Cantin, Marie-Ève Routhier et al. · Journal of Neuro-Oncology · 2024 · 12 citations

A phase 2 study of trametinib for patients with pediatric glioma or plexiform neurofibroma with refractory tumor and activation of the MAPK/ERK pathway.

Sébastien Perreault, Dorsa Sadat Kiaei, Mathieu Dehaes et al. · Journal of Clinical Oncology · 2022 · 11 citations

Pediatric Brain Tumors, Clinical Neurology, Pathology +27